VICTORY CAPITAL MANAGEMENT INC

Position in ZYME — Zymeworks Inc.

CIK 1040188 San Antonio, TX

Position in ZYME

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,111,577

+$49,781 QoQ

Shares Held

42,524

+0.3% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#86

of 202 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,534,997,913 across 158 Biotechnology names. ZYME ranks #72 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,173,152	$1,079,469,792
2	RPRX	Royalty Pharma plc	3,682,932	$206,501,997
3	INCY	Incyte Corp	1,480,342	$167,811,569
4	JAZZ	Jazz Pharmaceuticals plc	686,719	$165,478,677
5	LGND	Ligand Pharmaceuticals Inc	253,764	$80,212,262
6	REGN	Regeneron Pharmaceuticals, Inc.	126,343	$78,779,914
7	ALNY	Alnylam Pharmaceuticals, Inc.	172,842	$52,030,627
8	BNTX	BioNTech SE	539,787	$50,227,180

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,111,577	42,524	+0.3%	Shares	Sole	2026-08-07
2026-03-31	$1,061,796	42,404	-1.2%	Shares	Sole	2026-05-15
2025-12-31	$1,129,688	42,905	+24.3%	Shares	Sole	2026-02-13
2025-09-30	$589,430	34,510	-0.3%	Shares	Sole	2025-11-12
2025-06-30	$434,355	34,610	-21.8%	Shares	Sole	2025-08-13
2025-03-31	$527,255	44,270	-14.2%	Shares	Sole	2025-05-02
2024-12-31	$755,131	51,580	-5.2%	Shares	Sole	2025-02-06
2024-09-30	$682,594	54,390	-6.7%	Shares	Sole	2024-11-05
2024-06-30	$496,133	58,300	+23.5%	Shares	Sole	2024-08-05
2024-03-31	$496,544	47,200	-61.7%	Shares	Sole	2024-05-03
2023-06-30	$1,065,398	123,310	-18.8%	Shares	Sole	2023-07-27
2023-03-31	$1,373,628	151,950	—	Shares	Sole	2023-05-02
No filing history on record for this holder in this stock.